tiprankstipranks
Trending News
More News >
Nagaileben Co., Ltd. (JP:7447)
:7447
Japanese Market

Nagaileben Co., Ltd. (7447) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7447

Nagaileben Co., Ltd.

(7447)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
¥2,031.00
▲(12.21% Upside)
Score is driven primarily by strong financial resilience (debt-free balance sheet) and still-solid profitability, partially offset by weakening revenue momentum and inconsistent cash-flow conversion. Technical signals are soft/neutral, while valuation is supported by a high dividend yield but constrained by a mid-to-higher P/E.
Positive Factors
Debt-Free Balance Sheet
A debt-free balance sheet provides financial flexibility and low solvency risk, allowing the company to navigate economic fluctuations effectively.
Shareholder Returns
Active share repurchases and dividend payouts reflect a strong commitment to enhancing shareholder value and optimizing capital structure.
Profitability
Strong profitability with healthy margins indicates solid earnings power, supporting sustainable operations and potential for reinvestment.
Negative Factors
Revenue Decline
A sharp decline in revenue suggests potential demand pressure or market challenges, impacting long-term growth prospects.
Cash Flow Volatility
Inconsistent cash flow conversion and recent declines in free cash flow growth could strain financial flexibility and investment capacity.
Profit Decline
Significant declines in profitability metrics indicate challenges in maintaining operational efficiency and could pressure future earnings.

Nagaileben Co., Ltd. (7447) vs. iShares MSCI Japan ETF (EWJ)

Nagaileben Co., Ltd. Business Overview & Revenue Model

Company DescriptionNagaileben Co., Ltd. is a Japanese company primarily engaged in the manufacturing and sale of medical and healthcare wear. The company produces uniforms and clothing items for healthcare professionals, including doctors, nurses, and other medical staff. Known for its high-quality materials and innovative designs, Nagaileben is a leader in the healthcare apparel sector in Japan.
How the Company Makes MoneyNagaileben Co., Ltd. generates revenue through the design, manufacture, and sale of healthcare and medical wear. Its key revenue streams include direct sales to hospitals, clinics, and other medical institutions, as well as partnerships with distributors and retailers who sell their products. The company focuses on product differentiation through the use of advanced materials and functional designs that cater to the specific needs of healthcare professionals, which in turn helps to maintain a competitive edge and secure long-term contracts with medical institutions. Additionally, Nagaileben may also engage in licensing agreements or collaborations with other companies to expand its product offerings and market reach.

Nagaileben Co., Ltd. Financial Statement Overview

Summary
Overall financial profile is resilient: a debt-free, very conservative balance sheet supports low solvency risk (strongest factor). Profitability remains solid, but revenue momentum has weakened with a sharp latest-period decline, and cash flow conversion has been inconsistent with a recent drop in free cash flow growth.
Income Statement
74
Positive
Profitability is strong, with consistently healthy gross and net margins across the period, but momentum has weakened. Revenue has been flat-to-down in recent years and the latest annual period shows an unusually sharp revenue decline alongside softer margins versus prior years, indicating potential demand pressure or normalization after stronger periods. Overall: solid earnings power, but top-line trajectory is a clear near-term concern.
Balance Sheet
92
Very Positive
The balance sheet is very conservative with zero debt and a large equity base relative to assets, providing meaningful financial flexibility and low solvency risk. Returns on equity remain positive but are moderate and have drifted down from earlier years, suggesting profitability is not fully translating into high shareholder returns despite the strong capital position.
Cash Flow
63
Positive
Cash generation is positive with free cash flow remaining solid and generally tracking net income reasonably well, but cash conversion is inconsistent. In several years, operating cash flow covered net income by less than 1x, and the most recent period shows a steep drop in free cash flow growth, signaling volatility in working capital and/or investment spending that could pressure cash generation if earnings soften further.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.98B16.98B16.41B17.18B17.75B17.56B
Gross Profit6.71B6.57B7.03B7.55B7.88B8.06B
EBITDA3.96B3.99B4.27B4.88B5.31B5.53B
Net Income2.57B2.57B2.82B3.23B3.78B3.65B
Balance Sheet
Total Assets44.69B44.69B46.73B47.38B47.35B46.43B
Cash, Cash Equivalents and Short-Term Investments24.25B24.25B26.35B27.16B28.56B27.88B
Total Debt0.000.000.000.000.000.00
Total Liabilities3.37B3.37B4.03B4.16B5.09B4.40B
Stockholders Equity41.32B41.32B42.70B43.21B42.26B42.03B
Cash Flow
Free Cash Flow-368.00M1.89B2.12B1.53B3.33B4.20B
Operating Cash Flow-231.00M2.18B2.29B1.81B3.44B4.45B
Investing Cash Flow2.33B1.11B-1.77B3.42B-471.43M-3.26B
Financing Cash Flow-2.88B-3.89B-2.93B-2.94B-3.20B-1.97B

Nagaileben Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1810.00
Price Trends
50DMA
1855.52
Negative
100DMA
1870.08
Negative
200DMA
1939.00
Negative
Market Momentum
MACD
-18.56
Positive
RSI
40.20
Neutral
STOCH
17.12
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7447, the sentiment is Negative. The current price of 1810 is below the 20-day moving average (MA) of 1822.50, below the 50-day MA of 1855.52, and below the 200-day MA of 1939.00, indicating a bearish trend. The MACD of -18.56 indicates Positive momentum. The RSI at 40.20 is Neutral, neither overbought nor oversold. The STOCH value of 17.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7447.

Nagaileben Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥33.24B23.273.23%6.98%-42.05%
75
Outperform
¥95.52B19.121.79%10.76%54.82%
74
Outperform
¥114.32B14.072.66%7.56%-17.12%
72
Outperform
¥13.39B14.404.80%4.49%26.84%
71
Outperform
¥53.49B22.215.17%3.48%-6.35%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
57
Neutral
¥18.46B-9.824.15%-289.87%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7447
Nagaileben Co., Ltd.
1,786.00
-159.71
-8.21%
JP:3104
Fujibo Holdings, Inc.
8,610.00
3,615.04
72.37%
JP:3109
Shikibo Ltd.
1,080.00
129.45
13.62%
JP:3201
Japan Wool Textile Co., Ltd.
1,861.00
577.64
45.01%
JP:3529
Atsugi Co., Ltd.
1,152.00
140.00
13.83%
JP:3580
KOMATSU MATERE Co., Ltd.
869.00
111.50
14.72%

Nagaileben Co., Ltd. Corporate Events

Nagaileben Completes Treasury Share Disposal for Director Restricted Stock Compensation
Jan 9, 2026

Nagaileben Co., Ltd. has completed the payment procedures for a previously approved disposal of treasury shares to be used as restricted share-based remuneration for its directors, implementing a resolution passed by its Board of Directors on December 12, 2025. The transaction involves the disposal of 17,699 common shares at ¥1,873 per share, for a total of ¥33,150,227, allocated to six directors who are not Audit & Supervisory Committee members, underscoring the company’s continued use of equity-based compensation to align management interests with shareholders and reinforce its governance and incentive structure.

The most recent analyst rating on (JP:7447) stock is a Buy with a Yen2031.00 price target. To see the full list of analyst forecasts on Nagaileben Co., Ltd. stock, see the JP:7447 Stock Forecast page.

Nagaileben Nearly Maxes Out ¥1 Billion Share Buyback Authorization
Dec 26, 2025

Nagaileben Co., Ltd. has completed a share repurchase program authorized by its board of directors on November 12, 2025, under provisions of the Companies Act, acquiring 387,500 of its own common shares via market purchases on the Tokyo Stock Exchange between December 1 and December 26, 2025, at a total cost of ¥736,575,900. As a result, cumulative buybacks under this resolution now total 528,000 shares for ¥999,991,400, essentially reaching the ¥1.0 billion ceiling and signaling management’s active use of share repurchases to optimize capital structure and enhance shareholder value within the authorized 600,000-share limit.

Nagaileben Posts Weaker Q1 but Keeps Outlook for FY2026 Growth and Normalized Dividend
Dec 25, 2025

For the three months ended November 30, 2025, Nagaileben reported a 9.0% year-on-year decline in net sales to ¥2,920 million and a sharper drop in profitability, with operating profit down 28.8% to ¥412 million and profit attributable to owners of parent down 23.2% to ¥317 million, while total assets and equity also decreased slightly but the equity ratio remained above 90%. The company kept its previous guidance unchanged, forecasting a recovery for the fiscal year ending August 31, 2026, with net sales expected to grow 6.0% to ¥18,000 million and profit attributable to owners of parent to rise 12.7% to ¥2,900 million, alongside a planned reduction in the annual dividend to ¥60 per share following the inclusion of a one-off commemorative dividend in the prior year, signaling a normalization of shareholder returns and expectations of moderate earnings growth despite the weak first quarter.

Nagaileben Co., Ltd. Announces Disposal of Treasury Shares for Director Remuneration
Dec 12, 2025

Nagaileben Co., Ltd. has announced a decision to dispose of 17,699 treasury shares as part of a restricted share-based remuneration plan for its directors. This move is intended to align the interests of directors with shareholders by linking their compensation to the company’s stock performance, thereby incentivizing them to enhance corporate value. The disposal will result in a minimal dilution of 0.06% of the total issued shares, which the company considers reasonable for achieving the plan’s objectives.

Nagaileben Co., Ltd. Advances Share Buyback Plan
Dec 1, 2025

Nagaileben Co., Ltd. has announced the ongoing acquisition of its own shares, with 140,500 shares acquired at a cost of ¥263,415,500. This move is part of a larger plan approved by the Board of Directors to acquire up to 600,000 shares, aiming to enhance shareholder value and optimize capital structure.

Nagaileben Co., Ltd. Announces Share Buyback to Enhance Shareholder Value
Nov 12, 2025

Nagaileben Co., Ltd. has announced a strategic decision to acquire up to 600,000 of its own shares, representing 1.97% of its total issued shares, with a budget of up to ¥1.0 billion. This move is aimed at implementing a flexible capital policy to adapt to future business environment changes and enhance shareholder value, reflecting the company’s ongoing commitment to shareholder returns.

Nagaileben Announces Treasury Shares Cancellation and Reserve Reversal
Nov 12, 2025

Nagaileben Co., Ltd. announced the cancellation of 5,000,000 treasury shares, which constitutes 14% of its outstanding shares, and a reversal of its general reserve to facilitate this cancellation. This strategic move, scheduled for November 28, 2025, is an accounting transfer within the net assets section and will not impact the company’s profitability, maintaining its financial stability.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025